Clinical Trial

Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This randomized phase III trial studies standard or comprehensive radiation therapy in treating patients with early-stage breast cancer who have undergone surgery. Radiation therapy uses high-energy x rays to kill tumor cells. It is not yet known whether comprehensive radiation therapy is more effective than standard radiation therapy in treating patients with breast cancer
Protocol Amendment History 47 amendments
This ClinicalTrials.gov record has been amended 47 times since 2013-06-06; most recent amendment 2023-12-20.
Status change: Recruiting → Active, Not Recruiting 2022-05-06
Status change: Not Yet Recruiting → Recruiting 2013-08-23
Trial Details
NCT Number NCT01872975
Lead Sponsor NSABP Foundation Inc
Collaborators: National Cancer Institute (NCI), Radiation Therapy Oncology Group
Conditions Stage IB Breast Cancer, Stage II Breast Cancer
Enrollment 1,636 participants
Start Date 2013-08
Primary Completion 2023-09-14 (estimated)
Study Completion 2028-08 (estimated)
Updated on ClinicalTrials.gov 2023-12-27